
|Articles|June 1, 2010
- Pharmaceutical Executive-06-01-2010
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2010
Emerging Pharma Leaders
Advertisement
Articles in this issue
almost 16 years ago
Emerging Pharma Leaders 2010about 16 years ago
Pew's Rising Profile in Public Healthabout 16 years ago
Moving Beyond Claims-Based Messagingabout 16 years ago
Managing Business Synergiesabout 16 years ago
Post-Approval Regulation: Progress or Pileup?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5




